These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 5560183

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Production of a myocardial depressant factor in cardiogenic shock.
    Glenn TM, Lefer AM, Martin JB, Lovett WL, Morris JN, Wangensteen SL.
    Am Heart J; 1971 Jul; 82(1):78-85. PubMed ID: 5581723
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mechanism of the protective effects of prostaglandins E1 and F2 alpha in canine endotoxin shock.
    Raflo GT, Wangensteen SL, Glenn TM, Lefer AM.
    Eur J Pharmacol; 1973 Oct; 24(1):86-95. PubMed ID: 4585594
    [No Abstract] [Full Text] [Related]

  • 6. Role of a myocardial depressant factor in the pathogenesis of circulatory shock.
    Lefer AM.
    Fed Proc; 1970 Oct; 29(6):1836-47. PubMed ID: 5482718
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Myocardial metabolism during acute shock induced by hemorrhage, endotoxin, or physostigmine infusion.
    Spitzer JJ.
    Recent Adv Stud Cardiac Struct Metab; 1973 Oct; 3():161-7. PubMed ID: 4619693
    [No Abstract] [Full Text] [Related]

  • 9. Shock.
    Gill W, Long WB.
    J R Coll Surg Edinb; 1972 Sep; 17(5):304-14. PubMed ID: 4561808
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Altered mitochondrial metabolism in circulatory shock.
    Mela L.
    Adv Exp Med Biol; 1977 Sep; 78():371-3. PubMed ID: 19942
    [No Abstract] [Full Text] [Related]

  • 15. Mechanism of the lack of a beneficial response to inotropic drugs in hemorrhagic shock.
    Lefer AM, Glenn TM, Lopez-Rasi AM, Kiechel SF, Ferguson WW, Wangensteen SL.
    Clin Pharmacol Ther; 1971 Sep; 12(3):506-16. PubMed ID: 5567802
    [No Abstract] [Full Text] [Related]

  • 16. Influence of hemodialysis on a myocardial depressant factor in hemorrhagic shock.
    Wangensteen SL, DeHoll JD, Kiechel SF, Martin J, Lefer AM.
    Surgery; 1970 Jun; 67(6):935-43. PubMed ID: 5429578
    [No Abstract] [Full Text] [Related]

  • 17. Serum myocardial depressant factor of burn shock.
    Baxter CR, Cook WA, Shires GT.
    Surg Forum; 1966 Jun; 17():1-2. PubMed ID: 5920908
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Oxygen consumption of the entire organism in animal and human shock].
    Neuhof H, Glaser E.
    Verh Dtsch Ges Inn Med; 1969 Jun; 75():383-6. PubMed ID: 5400160
    [No Abstract] [Full Text] [Related]

  • 20. Beneficial action of new angiotensin-converting enzyme inhibitor (SQ 14,225) in hemorrhagic shock in cats.
    Trachte GJ, Lefer AM.
    Circ Res; 1978 Oct; 43(4):576-82. PubMed ID: 210975
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.